- Home
- RLAY vs JACK Comparison
RLAY vs JACK Comparison
Compare RLAY & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- JACK
- Stock Information
- Founded
- RLAY 2015
- JACK 1951
- Country
- RLAY United States
- JACK United States
- Employees
- RLAY N/A
- JACK N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- JACK Restaurants
- Sector
- RLAY Health Care
- JACK Consumer Discretionary
- Exchange
- RLAY Nasdaq
- JACK Nasdaq
- Market Cap
- RLAY 811.8M
- JACK 740.8M
- IPO Year
- RLAY 2020
- JACK 1987
- Fundamental
- Price
- RLAY $3.92
- JACK $38.46
- Analyst Decision
- RLAY Strong Buy
- JACK Buy
- Analyst Count
- RLAY 10
- JACK 17
- Target Price
- RLAY $20.11
- JACK $54.50
- AVG Volume (30 Days)
- RLAY 1.4M
- JACK 488.6K
- Earning Date
- RLAY 02-28-2025
- JACK 02-25-2025
- Dividend Yield
- RLAY N/A
- JACK 4.59%
- EPS Growth
- RLAY N/A
- JACK N/A
- EPS
- RLAY N/A
- JACK N/A
- Revenue
- RLAY $10,006,000.00
- JACK $1,571,306,000.00
- Revenue This Year
- RLAY N/A
- JACK N/A
- Revenue Next Year
- RLAY N/A
- JACK $2.55
- P/E Ratio
- RLAY N/A
- JACK N/A
- Revenue Growth
- RLAY N/A
- JACK N/A
- 52 Week Low
- RLAY $3.50
- JACK $36.36
- 52 Week High
- RLAY $10.89
- JACK $76.56
- Technical
- Relative Strength Index (RSI)
- RLAY 41.60
- JACK 42.97
- Support Level
- RLAY $3.85
- JACK $37.85
- Resistance Level
- RLAY $4.19
- JACK $40.85
- Average True Range (ATR)
- RLAY 0.28
- JACK 1.86
- MACD
- RLAY -0.02
- JACK -0.05
- Stochastic Oscillator
- RLAY 24.80
- JACK 9.68
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About JACK Jack In The Box Inc.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.